Pharmacognos Pty Ltd is a limited by shares, Australian proprietary company. This corporation was registered on 1999-03-15 and was issued with the 086693325 ACN. Its Australian Business Number is 96086693325. Since 2014-01-13, the company is headquartered in NSW, post code 2131. The previous headquarters were located in NSW 2131 (from 2001-03-26 to 2014-01-13). Pharmacognos Pty Ltd was registered for the GST on 2000-07-01. Pharmacognos Pty Ltd has been using the Pharmacognos Pty Ltd trading name since 2000-04-18 (it needs to be noted that the Australian Business Register no longer collects or updates trading names). In total the company used 1 trading name. The company has also used 1 business name, namely Pharmacognos from 2006-11-24. The above data comes from the ABN database which was updated on 2014-06-15.
| Status | From | To |
|---|---|---|
| Active | Monday 1st November 1999 | current |
| Name | From | To |
|---|---|---|
| Pharmacognos Pty Ltd | Monday 1st November 1999 | current |
| Name | From | To |
|---|---|---|
| Pharmacognos | Friday 24th November 2006 | current |
| Name | From | To |
|---|---|---|
| Pharmacognos Pty Ltd | Tuesday 18th April 2000 | current |
| Location | From | To |
|---|---|---|
| NSW 2131 | Monday 13th January 2014 | current |
| NSW 2131 | Monday 26th March 2001 | Monday 13th January 2014 |
| Status | From | To |
|---|---|---|
| Registered | Saturday 1st July 2000 | current |
Advertisements
Contains public sector information licensed under the Creative Commons Attribution 3.0 Australia licence. Material on this website was obtained from publicly-accessible databases and is attributed to ©Commonwealth of Australia 2024 (http://data.gov.au, http://acnc.gov.au/ and http://abr.business.gov.au/), ©Intellectual Property Government Open Data 2024, ©ASIC - Company Register. While we try to make the information as precise and up-to-date as possible, we are aware the datasets are not always error-free. Aubiz.net will not take responsibility for any errors in the databases. The material provided should be treated as a starting point of more in-depth research, not as fact.